Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 34,933 shares, an increase of 81.8% from the June 15th total of 19,219 shares. Currently, 1.6% of the shares of the company are sold short. Based on an average trading volume of 35,762 shares, the short-interest ratio is presently 1.0 days.
Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after buying an additional 1,052 shares in the last quarter. Ascentis Independent Advisors purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the first quarter valued at approximately $31,000. Royal Bank of Canada purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at approximately $37,000. International Assets Investment Management LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $41,000. Finally, Advisory Services Network LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the third quarter worth $52,000.
Invesco Nasdaq Biotechnology ETF Stock Down 0.1%
Shares of Invesco Nasdaq Biotechnology ETF stock opened at $32.59 on Friday. Invesco Nasdaq Biotechnology ETF has a 52-week low of $21.87 and a 52-week high of $34.22. The company’s 50-day simple moving average is $30.64 and its 200-day simple moving average is $29.69. The firm has a market cap of $73.65 million, a price-to-earnings ratio of 17.03 and a beta of 0.60.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
See Also
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
